These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7437263)

  • 41. [Pharmacokinetics of prednisolone in adrenal insufficiency ].
    von Papen C; Benker G; Hackenberg K; Reinwein D
    Klin Wochenschr; 1982 Jul; 60(13):681-6. PubMed ID: 7120877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets.
    Al-Habet SM; Rogers HJ
    Eur J Clin Pharmacol; 1989; 37(4):423-6. PubMed ID: 2598978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.
    Kamada AK; Wiener MB; LaVallee NM; Scott MB; Selner JC; Szefler SJ
    Pharmacotherapy; 1997; 17(2):353-6. PubMed ID: 9085328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of prednisolone in asthmatic patients with a poor response to steroid treatment.
    Mortimer O; Grettve L; Lindström B; Lönnerholm G; Zetterström O
    Eur J Respir Dis; 1987 Nov; 71(5):372-9. PubMed ID: 3443161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics.
    Rose JQ; Yurchak AM; Meikle AW; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):1-14. PubMed ID: 7229914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prednisone and prednisolone bioavailability in renal transplant patients.
    Gambertoglio JG; Frey FJ; Holford NH; Birnbaum JL; Lizak PS; Vincenti F; Feduska NJ; Salvatierra O; Amend WJ
    Kidney Int; 1982 Apr; 21(4):621-6. PubMed ID: 7047863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacokinetics of prednisone and prednisolone.
    Pickup ME
    Clin Pharmacokinet; 1979; 4(2):111-28. PubMed ID: 378499
    [No Abstract]   [Full Text] [Related]  

  • 53. Absorption of prednisolone in patients with Crohn's disease.
    Shaffer JA; Williams SE; Turnberg LA; Houston JB; Rowland M
    Gut; 1983 Mar; 24(3):182-6. PubMed ID: 6826099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An evaluation of maprotiline intravenous kinetics and comparison of two oral doses.
    Maguire KP; Norman TR; Burrows GD; Scoggins BA
    Eur J Clin Pharmacol; 1980 Oct; 18(3):249-54. PubMed ID: 7439244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily.
    Faulkner JK; McGibney D; Chasseaud LF; Perry JL; Taylor IW
    Br J Clin Pharmacol; 1986 Jul; 22(1):21-5. PubMed ID: 2943308
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats.
    Gáll Z; Vancea S; Szilágyi T; Gáll O; Kolcsár M
    Eur J Pharm Sci; 2015 Feb; 68():106-13. PubMed ID: 25530452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.